Abundant Source of Plant-based Protein, Fat, & Fiber The increasing demand for plant-derived sources of protein coupled with increased awareness of the role dietary proteins play in nutrition and optimal health has prompted the agri-food industry to explore non-traditional sources of protein. Boasting excellent all-around nutritional value and superior digestibility, hemp seed protein has drawn…
Abundant Source of Plant-based Protein, Fat, & Fiber
The increasing demand for plant-derived sources of protein coupled with increased awareness of the role dietary proteins play in nutrition and optimal health has prompted the agri-food industry to explore non-traditional sources of protein. Boasting excellent all-around nutritional value and superior digestibility, hemp seed protein has drawn considerable interest from both the scientific and industrial sectors. In this article, the nutritional composition and health benefits of hemp protein are reviewed.
A complete protein and more
Protein-rich hemp seed has been an important source of nutrition for many cultures for thousands of years. Technically a nut, the seed typically contains about 25% protein, with considerable amounts of dietary fiber, high levels of iron, manganese, zinc, and magnesium. The two chief proteins in hemp seed are albumin and Edestin. Both proteins are readily digestible and contain significant amounts of all 9 essential amino acids. Additionally, hemp seed has very high amounts of the amino acid arginine. (1)
Hemp seed & protein efficacy
The safety and efficacy of hemp seed protein has been evaluated and is recognized by Health Canada’s Non-Prescription and Natural Health Products Directorate (NNHPD) which has assessed the evidence and has determined that hemp protein concentrate and hemp protein isolate are safe and efficacious sources of protein for use in natural health products, as per the NNHPD Workout Supplements Monograph 2016. The Monograph enables licensed natural health products to claim their hemp seed protein is a nutrition source in the maintenance of good health, helps repair and build body tissue, is a protein source for muscle protein synthesis, and assists in the building of lean muscle when combined with weight resistance training and good diet(2).
Hemp protein powder as food ingredient
Hemp-derived protein powder can also be used as an ingredient in conventional foods, baked goods, beverages, cereals, dairy products, pastas, and grain products, etc. Hemp protein powders can be used in a similar manner as flour from grains (e.g., wheat, barley, rice, corn, rye, oat) as well as dairy and soy-based protein powders. Also, a non-dairy milk and non-dairy spreads can be produced using hemp protein powder.
Hemp seeds & essential fatty acids
Oil from the hemp seed exceeds 80% in polyunsaturated fatty acids (PUFAs) and is a rich source of the essential fatty acids (EFAs) linoleic acid (18:2 omega-6) and alpha-linolenic acid (18:3 omega-3). The ratio of omega-6 to omega-3 (n6/n3) in hemp seed oil is typically between 2:1 and 3:1, the appropriate level for optimal human health.
Hemp seeds & fiber
Most of the fiber in a hemp seed lies in its outer hull or shell. However, even without the shells, hemp seeds are a good source of fiber, with three tablespoons containing approximately 1.2 g of fiber.
With its complement of 9 plant-based essential proteins, heart-healthy oils, and gut-friendly dietary fiber, the tiny hemp seed is poised and ready to take its place on the front line of the plant-based food revolution.
Euphytica, January 2004, Volume 140, Issue 1–2, pp 65–72
2. Agency Response Letter GRAS Notice – https://www.fda.gov/media/118583/download
Dr. Rick Green, President of Technology Development for KeyLeaf Life Sciences, delivered a presentation to healthcare professionals attending the biennial Health Vision 20/20 Conference Presented by the Office of Health Innovation in Saskatoon, Saskatchewan. The title of the presentation was “Innovating Health Beyond the Doctors Office – The KeyLeaf Story” and the topic session was…
Dr. Rick Green, President of Technology Development for KeyLeaf Life Sciences, delivered a presentation to healthcare professionals attending the biennial Health Vision 20/20 Conference Presented by the Office of Health Innovation in Saskatoon, Saskatchewan. The title of the presentation was “Innovating Health Beyond the Doctors Office – The KeyLeaf Story” and the topic session was “Beyond the Pill”.
“By ‘beyond the pill’ we’re talking about looking at what lies behind the need to take a prescription pharmaceutical pill or medicine,” said Dr. Green. “Yes, we take a pill for a certain ailment, but it goes back to what caused that ailment. Maybe the way we eat, maybe the lack of dietary nutrients? So, going ‘beyond the pill’ requires our asking, ‘what really caused the symptom that we’re now taking a pill to remedy?’ If we know the root cause of what’s causing the ailment, we may be able to give the consumer dietary options so they can delay taking that pill… or maybe they’ll never need to take the pill in the first place.”
Going “beyond the pill” includes getting the right plant-based ingredients/natural products included in your foods so that taking pharmaceutical pills and capsules becomes unnecessary. Now that we know how to identify and stabilize thousands of ingredients and bio-actives, we can enhance the nutritional profile of your soup, salad, or entrée by ensuring we maintain the desired ingredients and bio-actives in your food.
According to Dr. Green, we are currently witnessing a major shift in the food and nutrition industries, as the food industry includes a new focus of health and wellness for consumers. He additionally pointed out that the consumer is looking for natural, clean-label foods and natural nutraceutical supplements to reduce the dependence on pharmaceuticals. Consumers are becoming more educated and they’re taking a clinical approach to their food sources. For example, they know they can get antioxidants from blueberries and blackberries and these components may have health benefits.
“People are beginning to practice ‘personalized nutrition’ now,” Dr. Green observed. “It’s a preventative medicine-type approach using food and diet. You can do gene screening for any individual to get an idea of what diseases that person is individually susceptible to, so when they’re young they can start addressing that genetic predisposition through food choices to extend the time before that disease sets in.”
Thomas Edison is attributed with making a prescient statement in the latter part of the 19th Century: He said the doctor of the future will no longer treat the human frame with drugs, but rather will cure and prevent disease with nutrition. It’s taken more than 100 years, but thanks to decades of research and inventiveness by companies like KeyLeaf and others in the food ingredient, and health and wellness industries, the goal of global well-being is now further advanced as healthcare moves ‘beyond the pill’.
KeyLeaf Life Sciences (KeyLeaf) is pleased to announce the next stage in its relationship with strategic partner Canopy Growth Corporation (Canopy) (TSX:WEED,NYSE:CGC). KeyLeaf, a Saskatchewan based company, is becoming a wholly owned subsidiary of Canopy and will play a key role in Canopy’s pursuit of leadership in cannabis extraction, purification and fractionation. This relationship will allow KeyLeaf to…
KeyLeaf Life Sciences (KeyLeaf) is pleased to announce the next stage in its relationship with strategic partner Canopy Growth Corporation (Canopy) (TSX:WEED,NYSE:CGC). KeyLeaf, a Saskatchewan based company, is becoming a wholly owned subsidiary of Canopy and will play a key role in Canopy’s pursuit of leadership in cannabis extraction, purification and fractionation. This relationship will allow KeyLeaf to help shape the cannabis and hemp industry as part of a network of worldwide partners and progress KeyLeaf towards leadership in plant-based ingredients.
“This is a very exciting time for KeyLeaf,” says Dr. Rick Green, President of Intellectual Capital Generation. “Canopy has utilized KeyLeaf’s decades of success in plant-based extraction and innovation for some time and bringing our two parties closer is an indication of how successful our partnership has been. Expanding our relationship advances Saskatchewan to centre stage in the global marketplace for plant extracts and natural products.”
KeyLeaf is no stranger to innovation. KeyLeaf opened its doors in 1977 as POS Pilot Plant Corporation with a 54,000 sq. ft. research facility at the University of Saskatchewan in Saskatoon. Looking to nearby canola fields for its first project, progressive thinking and advanced technology enabled KeyLeaf to fundamentally create North America’s canola oil industry overnight. KeyLeaf has since been on the cutting edge of ingredient breakthroughs for over 40 years and has established a gold standard reputation for innovation in food research, nutraceuticals, bio-based products, and now cannabis and hemp.
After completing more than 5,400 projects for clients in more than 40 countries over the past four decades, and with an additional processing facility in Batavia, Illinois, KeyLeaf has renewed its commitment to the Agri-food industry by placing the development and commercialization of high value plant-based extracts, including CBD, at the core of all activity.
As the global community demands more from plants, KeyLeaf will continue to innovate in the areas of plant-based extracts and ingredients, supplying new insights and remaining an active contributor to research communities in Saskatchewan and across the world.
For more information, on KeyLeaf Life Sciences, visit www.keyleaf.ca.
KeyLeaf Life Sciences is a global ingredient and process technology company established over 45 years ago. Headquartered in Saskatoon, Saskatchewan, KeyLeaf is recognized around the world as a trusted expert in plant-based bioprocessing. KeyLeaf has worked with over 800 companies from more than 40 countries and continues to increase Saskatchewan’s global visibility as a hub for innovation.
About Canopy Growth Corporation
Canopy Growth (TSX:WEED,NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth’s subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. Canopy Growth has operations in over a dozen countries across five continents.
Canopy Growth’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.
Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships.
From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates eleven licensed cannabis production sites with over 4.7 million square feet of production capacity, including over one million square feet of GMP certified production space. For more information visit www.canopygrowth.com
Notice Regarding Forward Looking Statements
This news release contains “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Canopy Growth or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release. Examples of such statements include statements with respect to future product format offerings and throughput capabilities. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including the Company’s ability to satisfy provincial sales contracts or provinces purchasing all cannabis allocated to them, and such risks contained in the Company’s annual information form dated June 27, 2018 and filed with Canadian securities regulators available on the Company’s issuer profile on SEDAR at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities laws.
For more information, please contact
Vice-President Global Sales and Business Development
Canopy Growth Corporation Contact:
Partner, Beyond Brands
Client Marketing Advisor, William Joseph Communications